Under the deal, Recordati will purchase the rights of AstraZeneca’s Seloken / Seloken ZOK (metoprolol succinate) and associated Logimax fixed dose combination (metoprolol succinate and felodipine) treatments. In
Zykadia, which is to be subjected orally, is a selective inhibitor of the ALK gene. Capable of combining with other genes to form an abnormal fusion protein, the
The company has reported positive topline phase 3 results for the HELP study, which assessed the efficacy and safety of subcutaneously administered lanadeluma against placebo over 26 weeks
The priority review has been specifically designated for treatment of FL patients whose disease had relapsed or is in the refractory stage and had also received at least
The company will start a tender offer to purchase all of the issued and outstanding shares of Patheon for $35.00 per share in cash. Patheon is a pharmaceutical
The company’s MedImmune unit carried out the Pacific trial, met one of its primary endpoint of progression-free survival (PFS) in patients with locally-advanced, stage three non-small cell lung cancer (NSCLC).
Hikma has secured a complete response letter (CRL) from the FDA on the abbreviated new drug application (ANDA). According to Vectura, the FDA has categorised the CRL as
Post merger, INC Research shareholders are likely to hold nearly 53% stake in the combimned company. inVentiv shareholders will hold the remainder stake. The merger is expected to
Posimir is Durect’s investigational locally-acting and non-opioid analgesic, which is being developed to offer up to three days of continuous pain relief after surgery. Posimir is an investigational
The woman hailing from Virginia had filed a lawsuit against the American healthcare brand in the 2nd Circuit Court for the City of St. Louis, claiming that she
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.